Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04699188
Title Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

Advanced Solid Tumor



JDQ443 + TNO155

JDQ443 + Spartalizumab

JDQ443 + Spartalizumab + TNO155

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST